2646 related articles for article (PubMed ID: 16286016)
1. IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines.
Schmitz J; Owyang A; Oldham E; Song Y; Murphy E; McClanahan TK; Zurawski G; Moshrefi M; Qin J; Li X; Gorman DM; Bazan JF; Kastelein RA
Immunity; 2005 Nov; 23(5):479-90. PubMed ID: 16286016
[TBL] [Abstract][Full Text] [Related]
2. Characterization of signaling pathways activated by the interleukin 1 (IL-1) receptor homologue T1/ST2. A role for Jun N-terminal kinase in IL-4 induction.
Brint EK; Fitzgerald KA; Smith P; Coyle AJ; Gutierrez-Ramos JC; Fallon PG; O'Neill LA
J Biol Chem; 2002 Dec; 277(51):49205-11. PubMed ID: 12368275
[TBL] [Abstract][Full Text] [Related]
3. IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells.
Smithgall MD; Comeau MR; Yoon BR; Kaufman D; Armitage R; Smith DE
Int Immunol; 2008 Aug; 20(8):1019-30. PubMed ID: 18550585
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-33 requires CMRF35-like molecule-1 expression for induction of myeloid cell activation.
Shik D; Moshkovits I; Karo-Atar D; Reichman H; Munitz A
Allergy; 2014 Jun; 69(6):719-29. PubMed ID: 24735452
[TBL] [Abstract][Full Text] [Related]
5. New dog and new tricks: evolving roles for IL-33 in type 2 immunity.
Lott JM; Sumpter TL; Turnquist HR
J Leukoc Biol; 2015 Jun; 97(6):1037-48. PubMed ID: 25801770
[TBL] [Abstract][Full Text] [Related]
6. IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex.
Chackerian AA; Oldham ER; Murphy EE; Schmitz J; Pflanz S; Kastelein RA
J Immunol; 2007 Aug; 179(4):2551-5. PubMed ID: 17675517
[TBL] [Abstract][Full Text] [Related]
7. Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation.
Hayakawa H; Hayakawa M; Kume A; Tominaga S
J Biol Chem; 2007 Sep; 282(36):26369-80. PubMed ID: 17623648
[TBL] [Abstract][Full Text] [Related]
8. Interleukin (IL)-33 induces the release of pro-inflammatory mediators by mast cells.
Moulin D; Donzé O; Talabot-Ayer D; Mézin F; Palmer G; Gabay C
Cytokine; 2007 Dec; 40(3):216-25. PubMed ID: 18023358
[TBL] [Abstract][Full Text] [Related]
9. Crucial role of the interleukin 1 receptor family member T1/ST2 in T helper cell type 2-mediated lung mucosal immune responses.
Coyle AJ; Lloyd C; Tian J; Nguyen T; Erikkson C; Wang L; Ottoson P; Persson P; Delaney T; Lehar S; Lin S; Poisson L; Meisel C; Kamradt T; Bjerke T; Levinson D; Gutierrez-Ramos JC
J Exp Med; 1999 Oct; 190(7):895-902. PubMed ID: 10510079
[TBL] [Abstract][Full Text] [Related]
10. Administration of IL-33 induces airway hyperresponsiveness and goblet cell hyperplasia in the lungs in the absence of adaptive immune system.
Kondo Y; Yoshimoto T; Yasuda K; Futatsugi-Yumikura S; Morimoto M; Hayashi N; Hoshino T; Fujimoto J; Nakanishi K
Int Immunol; 2008 Jun; 20(6):791-800. PubMed ID: 18448455
[TBL] [Abstract][Full Text] [Related]
11. The role of IL-33 and its receptor ST2 in human nasal epithelium with allergic rhinitis.
Kamekura R; Kojima T; Takano K; Go M; Sawada N; Himi T
Clin Exp Allergy; 2012 Feb; 42(2):218-28. PubMed ID: 22233535
[TBL] [Abstract][Full Text] [Related]
12. IL-33 and IL-33 receptors in host defense and diseases.
Oboki K; Ohno T; Kajiwara N; Saito H; Nakae S
Allergol Int; 2010 Jun; 59(2):143-60. PubMed ID: 20414050
[TBL] [Abstract][Full Text] [Related]
13. Suppression of interleukin-33 bioactivity through proteolysis by apoptotic caspases.
Lüthi AU; Cullen SP; McNeela EA; Duriez PJ; Afonina IS; Sheridan C; Brumatti G; Taylor RC; Kersse K; Vandenabeele P; Lavelle EC; Martin SJ
Immunity; 2009 Jul; 31(1):84-98. PubMed ID: 19559631
[TBL] [Abstract][Full Text] [Related]
14. The essential role of single Ig IL-1 receptor-related molecule/Toll IL-1R8 in regulation of Th2 immune response.
Bulek K; Swaidani S; Qin J; Lu Y; Gulen MF; Herjan T; Min B; Kastelein RA; Aronica M; Kosz-Vnenchak M; Li X
J Immunol; 2009 Mar; 182(5):2601-9. PubMed ID: 19234154
[TBL] [Abstract][Full Text] [Related]
15. Human basophils and eosinophils are the direct target leukocytes of the novel IL-1 family member IL-33.
Pecaric-Petkovic T; Didichenko SA; Kaempfer S; Spiegl N; Dahinden CA
Blood; 2009 Feb; 113(7):1526-34. PubMed ID: 18955562
[TBL] [Abstract][Full Text] [Related]
16. A novel interleukin 33/ST2 signaling regulates inflammatory response in human corneal epithelium.
Lin J; Zhang L; Zhao G; Su Z; Deng R; Pflugfelder SC; Li DQ
PLoS One; 2013; 8(4):e60963. PubMed ID: 23585867
[TBL] [Abstract][Full Text] [Related]
17. IL-1, IL-18, and IL-33 families of cytokines.
Arend WP; Palmer G; Gabay C
Immunol Rev; 2008 Jun; 223():20-38. PubMed ID: 18613828
[TBL] [Abstract][Full Text] [Related]
18. IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo.
Carriere V; Roussel L; Ortega N; Lacorre DA; Americh L; Aguilar L; Bouche G; Girard JP
Proc Natl Acad Sci U S A; 2007 Jan; 104(1):282-7. PubMed ID: 17185418
[TBL] [Abstract][Full Text] [Related]
19. The IL-1 receptor accessory protein (AcP) is required for IL-33 signaling and soluble AcP enhances the ability of soluble ST2 to inhibit IL-33.
Palmer G; Lipsky BP; Smithgall MD; Meininger D; Siu S; Talabot-Ayer D; Gabay C; Smith DE
Cytokine; 2008 Jun; 42(3):358-64. PubMed ID: 18450470
[TBL] [Abstract][Full Text] [Related]
20. IL-33/ST2 axis in inflammation and immunopathology.
Milovanovic M; Volarevic V; Radosavljevic G; Jovanovic I; Pejnovic N; Arsenijevic N; Lukic ML
Immunol Res; 2012 Apr; 52(1-2):89-99. PubMed ID: 22392053
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
